Cargando...
Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
Lung squamous cell carcinoma (LSCC) is the most common subtype of non-small cell lung cancer. Immunotherapy has become an effective treatment in recent years, while patients showed different responses to the current treatment. It is vital to identify the potential immunogenomic signatures to predict...
Gardado en:
| Publicado en: | Front Genet |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485220/ https://ncbi.nlm.nih.gov/pubmed/33005178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00978 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|